PDS Biotechnology Corporation

NASDAQ:PDSB  
5.38
+0.39 (+7.82%)
Earnings Announcements

PDS Biotech Reports Fourth-Quarter Results

Published: 03/31/2022 12:19 GMT
PDS Biotechnology Corporation (PDSB) - Pds Biotech Provides Business Update and Reports Fourth-quarter and Full-year 2021 Financial Results.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.